Clinical Trials in Miami

Showing 2341-2360 of 9,821 trials

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

NCT05907629

CAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial \[a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing patients with stroke attributed to 70-99% intracranial atherosclerotic stenosis (ICAS) to aspirin plus ticagrelor, clopidogrel, or rivaroxaban.\] The primary goal of this ancillary study is to determine if MRI biomarkers can potentially identify ICAS patients who fail best medical management. The CAPTIVA-MRI study leverages the CAPTIVA trial design and implementation to capture information that will inform and facilitate the next generation of ICAS trials and the management of patients with ICAS.

StrokeIntracranial Atherosclerotic Stenosis (ICAS)

Yale University300 participantsStarted Jun 2024

Birmingham, Alabama, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +10 more locations

COMPLETEDNA< 1 mile

VLU Dressing Study

NCT03621592

The goal of the study is to investigate the effectiveness of Cutimed Sorbact (Study Device) in modifying bacterial load in venous leg ulcers (VLU).

Venous Leg Ulcer

University of Miami31 participantsStarted Aug 2018

Miami, Florida, United States

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

VLU Dressing Study

Find Trials by Condition in Miami

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Study of JK07 in Patients With Chronic Heart Failure

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

ERG Components in Schizophrenia and Bipolar Disorder Type I

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours